C Rad AB OMXSTO:CRAD_B:
TOMAS BLOMQUIST APPOINTED NEW CEO OF C-RAD
BLOMQUIST WILL TAKE OFFICE ON FEBRUARY 2, 2026
C-RAD Appoints Tomas Blomquist As CEO
Watch C-Rad's latest callC-Rad (Stockholm:CRAD B) Q4 2025 Earnings Call · Replay · Feb 12Read the transcript of C-Rad (Stockholm:CRAD B) Q4 2025 Earnings CallEarlier from C-Rad
- CRAD_B: Q3 saw 12% revenue growth, 19% EBIT margin, and strong Services, with EMEA leading gains
- C-RAD Q3 EBIT Up At SEK 21.2 Mln
- C-RAD AB: Quarterly Trading Report 2025 Q3
- C-Rad Wins Order From From Czech Hospital
- CRAD_B: Order intake up 11%, service orders up 86%, but revenue down 13% year-on-year
Later from C-Rad
- Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025
- CRAD_B: Service growth and recurring revenue offset lower product sales, supporting margin stability
- C-RAD publishes its annual report for 2025
- C Rad Q1 Adjusted EBIT SEK 22 Mln
- C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
Follow C-Rad into a list and get an email when it puts out news.
Follow C-Rad